Progress, Potential, and Possibilities Podcast / Show Breaking Stigma Around Digestive Health Issues - Eric Foster - Chief Commercial Officer, Ardelyx
What if the biggest barrier in healthcare today isn’t science - but stigma?
Eric Foster is Chief Commercial Officer at Ardelyx ( https://ardelyx.com/ ), a biopharmaceutical company where he leads global commercialization strategy for innovative therapies addressing high-burden gastrointestinal and cardiorenal diseases.
A seasoned biotech executive with over two decades of experience, Eric has built and scaled high-performing commercial organizations across some of the industry’s most complex and competitive markets.
Prior to Ardelyx, Eric held senior leadership roles at Amgen and Horizon Therapeutics, where he led rare disease and specialty business units, overseeing product launches, market access, and global growth strategy. Earlier in his career, he spent over a decade at GSK and began in commercial roles at Johnson & Johnson.
Eric is known for his expertise in rare disease commercialization, payer strategy, and building first-in-class market entry plans, with a strong focus on connecting patients to therapies and reducing barriers to care. He holds an MBA in Healthcare from Auburn University and a BA in Economics from the University of Georgia.
#IBSC #GutHealth #WomensHealth #HealthcareInnovation #Biotech #PharmaMarketing #LPGA #WomensSports #DigitalHealth #PatientAwareness #ChronicIllness #HealthEducation #MedicalInnovation #HealthcareMarketing #BehaviorChange #HealthStigma #ChronicDisease #Biopharma #HealthPodcast #FutureOfHealthcare